1,232
Views
137
CrossRef citations to date
0
Altmetric
Drug Evaluations

Benralizumab – a humanized mAb to IL-5Rα with enhanced antibody-dependent cell-mediated cytotoxicity – a novel approach for the treatment of asthma

, MD, , MD & , MD
Pages 113-118 | Published online: 05 Dec 2011

Bibliography

  • Lotvall J, Pullertis T. Treating asthma with Anti-IgE or Anti IL-5. Curr Pharm Des 1999;5:757-70
  • Kolbeck R, Kozhich A, Koike M, Medi-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell mediated cytotoxicity function. J Allergy Clin Immunol 2010;125(1):1344-53
  • Kotsimbos ATC, Hamid Q. IL5 and IL-5 receptor in Asthma. Mem Inst Oswaldo Cruz 1997;92(Suppl II):75-91
  • Busse W, Ring J, Huss-Marp J, Kahn JE. A review of treatment with mepolizumab, an anti-IL-5 mAb, in hypereosinophilic syndromes and asthma. J Allergy Clin Immunol 2010;125(4):803-13
  • Hadar P, Brightling CE, Hargadon B, Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009;360:973-84
  • Nair P, Pizzichini MMM, Kjarsgaard M, Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009;360:985-93
  • Stein ML, Villanueva JM, Buckmeier BK, Anti IL-5 (mepolizumab) therapy reduces eosinophil activations ex vivo and increases IL-5 and IL-5 receptor levels. J Allergy Clin Immunol 2008;121(6):1473-83
  • Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Eosinophil's role remains uncertain as Anti-Interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 2003;167:199-204
  • Migita M, Yamaguchi N, Mita S, Characterization of the human IL-5 receptors on eosinophils. Cell Immunol 1991;133:484-97
  • Rosenberg HF, Phipps S, Foster PS. Eosinophil trafficking in allergy and asthma. J Allergy Clin Immunol 2007;119:1303-10
  • Tavernier J, Devos R, Cornelis S, A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF. Cell 1991;66:1175-84
  • Zaks-Zilberman M, Harrington AE, Ishino T, Chaiken IM. Interleukin-5 receptor subunit oligomerization and rearrangement revealed by fluorescence resonance energy transfer imaging. J Biol Chem 2008;283:13398-406
  • Ogata N, Kouro T, Yamada A, JAK2 and JAK1 constitutively associate with an interleukin-5 (IL-5) receptor alpha and beta c subunit, respectively, and are activated upon IL-5 stimulation. Blood 1998;91:2264-71
  • Takaki S, Kanazawa H, Shiiba M, Takatsu K. A critical cytoplasmic domain of the interleukin-5 (IL-5) receptor alpha chain and its function in IL-5-mediated growth signal transduction. Mol Cell Biol 1994;14:7404-13
  • Koike M, Nakamura K, Furuya A, Establishment of humanized anti-interleukin-5 receptor alpha chain monoclonal antibodies having a potent neutralizing activity. Hum Antibodies 2009;18:17-27
  • Busse WW, Katial R, Gossage D, Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti–IL-5 receptor antibody, in a phase I study of subjects with mild asthma. J Allergy Clin Immunol 2010;125:1237-44
  • Gossage D, Geba G, Gillen A, A multiple ascending subcutaneous dose study of MEDI-563, A humanized anti-IL-5RA monoclonal antibody, in adult asthmatics (clinicaltrails.gov Identifier: NCT00783289). Annual Congress of the European Respiratory Society (ERS);2010

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.